Background: Studies examining the etiology-specific effects of diarrheal disease on growth are limited and variable in their analytic methods, making comparisons difficult and priority setting based on these findings challenging. A study by Black et al (Black RE, Brown KH, Becker S. Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh. Pediatrics. 1984;33:1004-1009 examined the association between Shigella and enterotoxigenic Escherichia coli-related disease and weight gain and linear growth in Bangladeshi children aged 0-5 years. We estimated similar associations in a 2002 cohort of 0-to 6-year-old children in the Peruvian Amazon. Methods: Diarrheal surveillence was conducted using household visits 3 times per week. Anthropometry was collected monthly. Mixed-effect models were used to estimate the association between Shigella, ETEC and Campylobacter diarrhea and weight gain in a 2-month period and linear growth over a 9-month period. Diarrheal disease burdens and growth intervals were quantified so as to be as comparable as possible to the original report. Results: Shigella-and ETEC-associated diarrhea were not associated with diminished weight gain, although the association between ETEC diarrhea and weight gain (−4.5 g/percent of days spent with ETEC, P = 0.098) was twice that of other etiologic agents, as well as similar in magnitude to the original report. Shigella-associated diarrhea was associated with decreased linear growth (0.055 cm less growth/percent days, P = 0.008), also similar to the original study. Conclusions: Our findings suggest that associations between enteropathogen-specific diarrheal episodes and growth, particularly Shigella, are comparable across geographic and epidemiological contexts.
D
iarrhea is a common cause of morbidity as well as mortality among children in the developing world. In addition to causing 750,000 deaths per year. 1 In the year 2010, it was estimated that the average child <5 in the developing world experiences 2.9 cases per year. 2 The effects of diarrheal disease on childhood malnutrition are well-studied, 3 having been found to negatively affect both weight gain 4 and linear growth, 5 and increase a child's risk of becoming stunted. 6 Because undernutrition in the first years of life is associated with poorer cognitive development, 7 decreased adult work capacity 8 and earnings 9 and poorer maternal health outcomes, 9 undernutrition is considered to be an important surrogate of human potential loss. It is widely felt that, in impoverished settings, "damage suffered in early life leads to permanent impairment". 9 In many studies relating diarrheal disease and growth, however, it has not been possible to identify diarrheal episodes by etiology. For this reason, the comparative effects of both diarrhea-associated and asymptomatic infections of common gastrointestinal infections remains an important area of study, with the effects of some pathogens better characterized than others. For instance, it has been observed that Cryptosporidium and E. histolytica, although frequently associated with asymptomatic infection or relatively mild diarrheal disease, nevertheless result in decreased linear growth [10] [11] [12] ; however, other pathogens frequently associated with severe diarrhea, such as rotavirus, have thus far not been strongly associated with any negative impact on growth. 13, 14 Effect sizes in these studies are small and the longitudinal models applied differ, making it difficult to compare the results of studies within and between pathogens in a comparative way.
ETEC and Shigella are principal causes of bacterial enteritis in children in the developing world. A 1984 study by Black et al 13 examined the effects of diarrheal disease associated with Shigella, rotavirus and enterotoxigenic Escherichia coli (ETEC), 3 etiological agents associated with diarrhea in infants and children in the developing world, on the weight gain and linear growth of Bangladeshi children in the first 5 years of life. This study found that greater time spent with ETEC-associated diarrhea was associated with less weight gain over a 2-month period (3 grams less weight gain per percent of days spent with ETEC diarrhea) and that time spent with Shigella-associated diarrhea was associated with poorer changes in linear growth over the course of a year (0.075 cm less linear growth per percent of days spent with ETEC diarrhea).
We recently reported that symptomatic Campylobacter, an invasive enteric organism frequently associated with acute but selflimiting diarrhea, 15 was associated with poorer growth among children 0-6 years of age living in a peri-urban Peruvian Amazonian community. 16 We have now applied a similar statistical methodology to Shigella-and ETEC-associated diarrhea in the same cohort, with adjustments to make our results as directly comparable as possible to the previous study and determine whether the findings are comparable across epidemiologic contexts.
MATERIALS AND METHODS
Data were from a prospective, community-based study of 442 children 0-72 months of age from 2002 to 2006 in a community near to Iquitos, Peru. Details of this cohort, including anthropometry and diarrheal surveillance methodology, have previously been reported. 17, 18 Children were followed up for varying periods because enrollment was ongoing throughout the study and because children aged out of the study at 72 months of age. Few children were lost to follow up when the family permanently migrated outside the study area or if they no longer wished to participate; however, gaps in data collection do exist for individual children because of temporary family migration. In brief, each child's length/height and weight were measured monthly, on the day of their birth. Children were weighed on Salter scales (Salter Housewares Ltd, Tonbridge, England). Length (children 0-23 months of age) or height (children 24-72 months of age) was measured using a marked platform with a sliding footboard. Data related to socioeconomic status were collected using 2 community censuses during the study period.
Participating families were visited 3 times weekly by a trained field worker to document the number and consistency of stools passed by the child over the previous 24-hour period. Diarrhea was defined by 3 or more liquid or semiliquid stools reported over a 24-hour period, with episodes separated by at least 3 symptom-free days. Stool samples were collected as soon as possible after the case definition for diarrhea was met, and not >2 days after the episode ended. One sample was sought for all episodes; however, children who were culture-negative for Campylobacter and Shigella but continued to have diarrhea were asked to provide a sample every fourth day until the episode ended.
Fresh stool samples were placed in a Cary-Blair medium and transported in a cooler from the field site for same-day plating. Standard methods were used to isolate Shigella and Campylobacter as described in previous reports. 17 Five lactose-positive colonies were additionally selected for polymerase chain reaction for heatlabile and heat-stable toxins for ETEC as per Stacy-Phipps et al. 19 Informed consent was obtained and the study protocol was approved by the institutional review boards of Johns Hopkins Bloomberg School of Public Health (Baltimore, MD), US Navy Medical Research Center (Silver Springs, MD), Asociacion Benefica PRISMA (Lima, Peru) and the Regional Health Authority for the Department of Loreto, Peru.
Statistical Methods
Poisson regression was used to calculate incidence rates of Shigella-associated, Campylobacter-associated and ETEC-associated diarrhea. Smoothed plots of incidence versus age were created (Fig. 1) .
Baseline characteristics and the incidence of overall diarrheal disease of children who experienced at least 1 case of Shigella, ETEC or Campylobacter-associated diarrhea during the course of the study were compared with children who did not.
The final weight gain and linear growth models are shown in Equations (1) and (2), respectively. The effects of Shigella-, ETEC-and Campylobacter-associated diarrhea on weight gain over 2-month intervals was evaluated using the model shown in Equation 1 . Two sets of independent variables were considered. 
In Equation (1) 
In Equation (2), the effects of Shigella-, ETEC-and Campylobacter-associated diarrhea on linear gain over 9-month intervals is evaluated. Here,Y ij represents the child's length/height at age i, and D shig , D campy and D ETEC represent the percentage of days associated with, and the total number of incident episodes of diarrhea associated with these pathogens over the prior 9 months. We chose a 9-month period over a 12-month period to maximize sample size 
Age (months)
Campylobacter-associated Diarrhea ETEC-associated Diarrhea Shigella-associated Diarrhea FIGURE 1. Incidence rate of etiologyspecific diarrhea.
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because of the data collection gaps caused by temporary family migration. These models were constructed similar to those previously reported 16 and included a random intercept for each study child and a covariance structure that assumed a second-order moving average correlation structure among the residuals for change-inweight models, and a first-order autoregressive correlation structure among the residuals for change-in-height models. Episodes of enteropathogen-associated diarrhea that were ongoing at or near to (≤2 days) the time of anthropometry were excluded from the weight models, to minimize the possibility that results would be influenced by dehydration caused by acute diarrhea. Coinfections (diarrheal episodes associated with 2 or more of the enteropathogens of interest) were double counted (eg, an episode associated with both Shigella and Campylobacter was counted once for each), and sensitivity analyses indicated that this did not bias our results.
Age terms were included as fractional polynomials, which is a method to adjust for curvilinear relationships, 20 and seasonal effects were considered by including the terms, sine d t ( ) 2 π and cosine d t ( ) 2 π to the model, where d is the day of the year and t is 365. 21 Other variables, such as those related to breast-feeding status, birth weight and socioeconomic status, were considered for appropriateness in the analysis and as possible confounding factors. Age, season, birth weight, logged per-capita income and nutritional status (stunting and weight-for-height categorized as >0, 0 to −1, and <−1) were retained in the final weight models, and all except birth weight were retained in the final linear growth models. All analysis was performed using Stata 11 (Statacorp, College Station, TX).
RESULTS
Of 442 children enrolled, 9 were excluded because of limited anthropometric data, defined as fewer than 3 consecutive months of anthropometry, or because they were >72 months of age. Out of a maximum of 11,311 child months of surveillance, the 433 remaining children yielded 838 total child years of surveillance (88.9%) and 10,985 completed monthly anthropometry visits (93.5%).
There were 3973 total episodes observed during the surveillance period. Of these, 3711 (93.4%) had at least 1 stool collected and tested in association with the episode. There were 320 Campylobacter-associated, 314 Shigella-associated and 387 ETEC-associated diarrheal episodes ( Table 1 ). The overall incidence of diarrheal disease in the study cohort was 4.8 episodes per child-year, peaking at 9.6 episodes per year among children 12-17 months of age.
The mean diarrheal prevalence, defined as the percentage of days in the overall study period spent with diarrhea, was 4.59% for all diarrhea (3.42% for diarrhea other than that caused by Shigella, Campylobacter or ETEC), 0.37% for Shigella-associated diarrhea, 0.45% for ETEC-associated diarrhea and 0.39% for Campylobacter-associated diarrhea.
The absolute incidence rates of Shigella-, Campylobacter-and ETEC-associated diarrhea were highest among children approximately 2 years of age (Fig. 1) . As a percentage of total diarrhea episodes, however, Shigella and ETEC were most common in older children, whereas Campylobacter made up a larger proportion of diarrheal episodes in younger children (those 13-36 months of age). The mean duration of these episodes was 3.5 days for all episodes of diarrhea, 3.7 days for episodes associated with Shigella, 3.8 for episodes associated with Campylobacter and 3.6 for episodes associated with ETEC.
Children who experienced at least 1 diarrheal event associated with these 3 pathogens during the course of the study had a higher incidence of diarrhea overall, were likely to have entered the study at a younger age and have remained in the study for a greater length of time before dropping out. Children who experienced at least 1 episode of Shigella-associated diarrhea were also more likely have experienced at least 1 episode of Campylobacterassociated diarrhea, at least 1 episode of ETEC-associated diarrhea and a greater than 75 th percentile diarrheal burden during the study period. In other words, children with these enteropathogens tended to be those with a high burden of diarrhea not attributed to these enteropathogens as well, and this was mostly because of their young age.
Growth Model Outcomes
Neither Shigella-or ETEC-associated diarrhea were significantly associated with poorer weight gain over a 2-month period, whether included in the model as incidence or as prevalence (the Diarrheal episodes were considered associated with a pathogen when at least 1 stool sample from the episode was culture positive for that pathogen. A stool sample was considered associated with the episode when it was collected during, or up to 1 day after, the episode. percentage of days in the interval spent with that diarrhea). Campylobacter-associated diarrheal incidence, as previously reported, was associated with poorer weight gain, as children were estimated to gain 55.3 g less weight per Campylobacter episode; however, no effect on weight gain was found when this was expressed as prevalence (2.9 g/percent, P = 0.267; Table 2 ). Over 9-month periods, Shigella diarrhea was associated with 0.081 cm less linear growth per diarrheal episode (P = 0.008) or 0.055 cm less linear growth per percent of days spent with Shigella diarrhea (P = 0.002; Table 3 ). Both ETEC-and Campylobacter-associated episodes of diarrhea were also associated with diminished linear growth when expressed as incidence (number of episodes occurring in the interval) but not as prevalence (percent of days spent with pathogen-associated diarrhea).
CONCLUSIONS
In 1984, Black et al 13 found that ETEC-associated diarrhea was associated with poorer weight gain over 2-month periods, with an estimated effect of 3 g less weight gain per percent of days with ETEC diarrhea, and Shigella-associated diarrhea was associated with 0.075 cm less gain in length per percent of days with Shigella over a year long period.
Surprisingly, there is consistency in our findings with those reported by Black et al. 13 Shigella-associated diarrhea was the pathogen most strongly associated with reduced linear growth: we estimated −0.055 cm less linear growth per percent of days with Shigella over a 9-month period (95% confidence interval: −0.089 to −0.020; Table 3 ). Although we did not find a significant impact of ETEC-associated diarrhea on weight gain (4.5 g less weight gain over 2 months, P = 0.098; Table 2 ), the magnitude of this coefficient was similar to that previously reported by Black et al.
Associations between diarrheal disease and poorer growth have been presented across cohorts and in a variety of epidemiologic contexts. Particularly when discussing pathogen-specific effects, however, the ability to draw conclusions has been hindered by variability in the manner of presentation of results. The retesting of hypotheses across study cohorts with the aim of presenting results in a comparable manner is not only an academic exercise, but also may prove important for priority setting for research and policy.
Our models are not the same as those used by Black et al. We did, however, choose the same 2-month interval of analysis to compare associations between enteropathogens and weight gain. A slightly shorter (9 months rather than 1 year) interval was used to test the effects for linear growth, as a longer interval resulted in a diminished quantity of data available for analysis. We also used the same exposure variables (percent of days in the interval with Shigella-associated or ETEC-associated diarrhea) chosen by Black et al.
Our cohort was of similar age (0-6 years) to that of the Black et al's study (0-5 years). The overall incidence of diarrheal disease peaked at 9.6 episodes/yr in children 12-17 months of age. This was similar to the Bangladeshi cohort, in which the overall incidence peaked at approximately 7 episodes/child-year in children 2-11 months of age. 22 In the Bangladeshi cohort, the incidence of E. coli-associated diarrhea was about 2 per child-year, and incidence of Shigella-associated diarrhea was <1 episode per childyear. 22 Our rates of enteropathogen-specific diarrhea were slightly lower (<1 per year).
The most significant contrast between the 2 cohorts was in the prevalence of diarrheal episodes, rather than in their incidence. The mean duration of episodes in our Peruvian cohort was 3.5 days, and only 2.4% of episodes became persistent (≥14 days duration). The original Bangladeshi cohort had a reported median duration of 4-5 days for overall diarrhea, and 8.0% lasted 20 days or more. 22 This trend was even more pronounced for shigellosis, which had a median duration of 7 days, with 16% of Shigella episodes lasting 20 days or more. 22 As a result of this difference, and in spite of a slightly less stringent diarrheal definition (≥3 liquid or semiliquid stools vs. ≥4 liquid stools/d), the mean percent of days with Shigella-associated and ETEC-associated diarrhea in our cohort was much lower than what was reported by Black (0.4% vs. 2.8% of days with Shigella, 0.5% vs. 3.8% of days with ETEC, and 3.4% vs. 12.8% of days with other-cause diarrheas; 4.6% of days with overall diarrhea).
As undernutrition is more strongly associated with diarrheal duration than with incidence, 23, 24 it is also relevant that our study population appears to have had less acute malnutrition than the previous cohort. 25 Further, only 11.6% of children in our cohort were reported to weigh <2.5 kg at birth, whereas studies in South Asia frequently report a high incidence of low birth weight and intrauterine growth retardation. 26 For instance, Roy 27 found that between 30 and 40% of newborns in Bangladesh weighed <2.5 kg at birth.
As a result, despite our replication of the association between specific enteropathogens and growth, the cumulative impact of enteropathogen-specific diarrheal disease and growth might be expected to vary between the 2 cohorts. If calculated based on disease prevalence, the Bangladeshi cohort spent many more days with diarrhea than did the Peruvian cohort, and therefore, the expected cumulative impact of these infections on growth would be greater in the earlier cohort. At least 1 study has found that the longitudinal prevalence of diarrhea is more predictive of weight gain than is diarrheal incidence. 28 In our own data, however, comparisons of model fit suggested that diarrheal incidence explained more of the variability in weight gain and linear growth than did prevalence. However, for the sake of comparability, we present both prevalence and incidence models here. 
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There are other relevant differences between the 2 cohorts. The etiologies of diarrhea in the "other-cause" diarrhea category are likely to have been distinct. Rotavirus was a common enteropathogen considered alongside Shigella and E. coli in the Bangladeshi study. In our cohort, most samples were not tested for rotavirus, although national estimates from the same period suggest that it is likely to have been common. 29 Other bacterial causes of diarrhea including Aeromonas, Salmonella and Vibrio cholerae were tested for but found to be rare and can also be excluded as frequent enteropathogens in the Peruvian cohort. In a subset of stools, norovirus was found in 21.3% of diarrheal stool samples and 3% of non-diarrheal stools 30 making this also a likely significant cause of diarrhea in this setting.
According to study protocol, for cases in which the child was still symptomatic when bacteriological culture confirmed a positive enteropathogen result, appropriate antibiotic therapy was administered. The exception to this was where dysentery was reported, in which case an antibiotic was given as soon as the specimen was received (before the result of cultures), in which case the therapy was guided by known patterns of antibiotic resistance of Shigella isolates in the community. As a result, the likelihood of treatment across the 3 pathogens was not similar. Nearly 40% [39.8% (125)] of Shigella-associated diarrheal episodes were treated with effective antibiotics, as opposed to only 18.9% of Campylobacter and 5.2% of ETEC-associated episodes. For this reason, it should be considered that the effects of Shigella may also be less severe in this population than in circumstances in which a smaller percentage of diarrheal episodes are correctly and promptly treated. The serogroups of Shigella present were similar to what was reported in the Bangladeshi cohort, as 67.1% of Shigella isolates were flexneri, 11.8% sonnei, 11.4% boydii and 2.4% dysenteriae 31 ; in the Bangladeshi community, 67% were flexneri and the other 3 serogroups "were each responsible from 9 to 12%" of Shigella episodes. 22 Risk factors for Shigellaassociated diarrhea in Peru have been previously reported and include less maternal education, the lack of a piped water supply and lower weight-for-age. 17 Our findings reinforce the relative importance of Shigella-associated diarrhea as a cause of growth faltering. Clinical dysentery syndrome is associated with damage to the intestinal structure and function and greater endogenous protein loss than non-dysentery diarrheas, 32 and Shigella is the most common cause of endemic dysentery in this and in most epidemiological contexts.
Poor linear growth in early childhood is associated with cognitive deficits, lower adult work capacity and poor maternal outcomes and is therefore a marker for human potential lost. 8, 33, 34 The consistent and diferential long-term effects attributable to select enteropathogens provide support for prioritization of accelerated vaccines, diagnostics and treatments targeted at those pathogens causing the greatest degree of long-term morbidity, as well as those causing acute mortality.
